Exagen Inc

NASDAQ:XGN  
14.86
-0.24 (-1.59%)
Earnings Announcements

Exagen Inc. Reports Third Quarter 2020 Results

Published: 11/10/2020 21:28 GMT
Exagen Inc (XGN) - .
Reports Third Quarter 2020 Results.
Q3 Revenue $10.8 Million Versus Refinitiv Ibes Estimate of $8.9 Million.
Qtrly Loss per Share $0.34.
Q3 Earnings per Share View $-0.47 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $10.17 Million
Adjusted EPS is expected to be -$0.43

Next Quarter Revenue Guidance is expected to be $11.44 Million
Next Quarter EPS Guidance is expected to be -$0.40

More details on our Analysts Page.